Immunotherapy and fatigue: what we know and what we don't know.
作者信息
Azeem Khan Muhammad, Florou Vaia, Swami Umang
出版信息
Oncotarget. 2021 Apr 13;12(8):719-720. doi: 10.18632/oncotarget.27946.
Abstract
摘要
相似文献
1
Immunotherapy and fatigue: what we know and what we don't know.免疫疗法与疲劳：我们所知与未知的情况
Oncotarget. 2021 Apr 13;12(8):719-720. doi: 10.18632/oncotarget.27946.
2
Knowing that you don't know: metamemory and discourse processing.自知无知：元记忆与话语处理
J Exp Psychol Learn Mem Cogn. 1997 Nov;23(6):1378-93. doi: 10.1037//0278-7393.23.6.1378.
3
Education-based disparities in knowledge of novel health risks: The case of knowledge gaps in HIV risk perceptions.基于教育的新型健康风险知识差距：以 HIV 风险认知中的知识差距为例。
Br J Health Psychol. 2018 May;23(2):420-435. doi: 10.1111/bjhp.12297. Epub 2018 Jan 31.
4
An examination of "don't know" responses in forensic interviews with children.对儿童法医面谈中“不知道”回答的一项调查。
Behav Sci Law. 2014 Nov-Dec;32(6):746-61. doi: 10.1002/bsl.2141. Epub 2014 Nov 25.
5
Anti-Vascular Endothelial Growth Factor Therapy in Pregnancy: What We Know, What We Don't Know, and What We Don't Know We Don't Know.孕期抗血管内皮生长因子治疗：我们已知的、未知的以及我们不知道自己不知道的。
Retina. 2016 Aug;36(8):1413-7. doi: 10.1097/IAE.0000000000001200.
6
The effect of a 'don't know' option on test scores: number-right and formula scoring compared.“不知道”选项对考试成绩的影响：正确题数计分与公式计分的比较
Med Educ. 1999 Apr;33(4):267-75. doi: 10.1046/j.1365-2923.1999.00292.x.
7
"I don't know" responses in elderly depressives and in dementia.老年抑郁症患者和痴呆症患者的“我不知道”回答。
J Am Geriatr Soc. 1985 Apr;33(4):253-7. doi: 10.1111/j.1532-5415.1985.tb07112.x.
8
Correlates of the "don't know" response to questions about snoring.对打鼾问题回答“不知道”的相关因素。
Am J Respir Crit Care Med. 1999 Dec;160(6):1812-5. doi: 10.1164/ajrccm.160.6.9807082.
9
How do you know what you don't know, if you don't know?如果你不知道，你怎么知道自己不知道什么？
Oper Dent. 2003 Mar-Apr;28(2):107-8; discussion 108.
10
Data Scientists: They know what we don't know that we don't know about Big Data.数据科学家：他们知道我们所不知道的关于大数据的未知之事。
Ear Nose Throat J. 2016 Aug;95(8):302-5.
引用本文的文献
1
Chronic Fatigue in Cancer Survivorship: Psychiatry Versus Oncology or Psychiatry with Oncology?癌症幸存者的慢性疲劳：精神科与肿瘤科之争，还是精神科联合肿瘤科？
Curr Oncol Rep. 2025 Jun 11. doi: 10.1007/s11912-025-01697-9.
2
Experience of patients considering or using checkpoint inhibitors in cancer treatment: a systematic review of qualitative research.癌症治疗中考虑或使用检查点抑制剂的患者体验：定性研究的系统评价。
J Immunother Cancer. 2024 Jan 11;12(1):e007555. doi: 10.1136/jitc-2023-007555.
3
Real-World Effectiveness, Safety, and Health-Related Quality of Life in Patients Receiving Adjuvant Nivolumab for Melanoma in Belgium and Luxembourg: Results of PRESERV MEL.在比利时和卢森堡接受辅助性纳武利尤单抗治疗黑色素瘤患者的真实世界有效性、安全性及健康相关生活质量：PRESERV MEL研究结果
Cancers (Basel). 2023 Sep 30;15(19):4823. doi: 10.3390/cancers15194823.
4
Biomarker Trends, Incidence, and Outcomes of Immune Checkpoint Inhibitor-Induced Myocarditis.生物标志物趋势、免疫检查点抑制剂诱发心肌炎的发病率及转归
JACC CardioOncol. 2022 Dec 20;4(5):689-700. doi: 10.1016/j.jaccao.2022.11.004. eCollection 2022 Dec.
本文引用的文献
1
Associations between the gut microbiome and fatigue in cancer patients.肠道微生物组与癌症患者疲劳的关联。
Sci Rep. 2021 Mar 12;11(1):5847. doi: 10.1038/s41598-021-84783-9.
2
Testosterone deficiency in men receiving immunotherapy for malignant melanoma.接受恶性黑色素瘤免疫治疗的男性的睾酮缺乏症。
Oncotarget. 2021 Feb 2;12(3):199-208. doi: 10.18632/oncotarget.27876.
3
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline Summary.接受免疫检查点抑制剂治疗患者免疫相关不良事件的管理：美国临床肿瘤学会临床实践指南摘要
J Oncol Pract. 2018 Apr;14(4):247-249. doi: 10.1200/JOP.18.00005. Epub 2018 Mar 8.
4
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade.与免疫检查点阻断相关的免疫相关不良事件。
N Engl J Med. 2018 Jan 11;378(2):158-168. doi: 10.1056/NEJMra1703481.
5
Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies.抗程序性死亡蛋白1（PD-1）和抗程序性死亡配体1（PD-L1）免疫检查点抗体的毒性。
Ann Oncol. 2015 Dec;26(12):2375-91. doi: 10.1093/annonc/mdv383. Epub 2015 Sep 14.
6
Cancer-related fatigue--mechanisms, risk factors, and treatments.癌症相关疲劳——机制、风险因素及治疗方法
Nat Rev Clin Oncol. 2014 Oct;11(10):597-609. doi: 10.1038/nrclinonc.2014.127. Epub 2014 Aug 12.
7
Inflammation and cancer-related fatigue: mechanisms, contributing factors, and treatment implications.炎症与癌症相关疲劳：机制、影响因素及治疗意义。
Brain Behav Immun. 2013 Mar;30 Suppl(0):S48-57. doi: 10.1016/j.bbi.2012.06.011. Epub 2012 Jul 6.
8
Improved survival with ipilimumab in patients with metastatic melanoma.Ipilimumab 改善转移性黑色素瘤患者的生存。
N Engl J Med. 2010 Aug 19;363(8):711-23. doi: 10.1056/NEJMoa1003466. Epub 2010 Jun 5.
Zotero 插件